| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.07 | 0.7 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.072 | 0.7 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |